EI
WVE icon

EAM Investors’s Wave Life Sciences WVE Stock Holding History

EAM Investors’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-248,815
Closed -$4.23M – 387
2025
Q4 		$4.23M Buy
+248,815
New +$2.53M 0.47% 109
2025
Q2 		– Sell
-213,848
Closed -$1.73M – 359
2025
Q1 		$1.73M Sell
213,848
-869
-0.4% -$9.5K 0.3% 144
2024
Q4 		$2.66M Buy
+214,717
New +$2.87M 0.38% 132
2018
Q2 		– Sell
-54,522
Closed -$2.19M – 358
2018
Q1 		$2.19M Buy
+54,522
New +$2.29M 0.36% 134

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

EAM Investors's WVE Position: Q1 2026 in Review

EAM Investors sold out of Wave Life Sciences (WVE) in Q1 2026, closing a stake of 248,815 shares — an estimated $4.23M sold.

EAM Investors first reported a position in WVE in Q1 2018 and held it in 4 quarters. The position peaked at $4.23M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • EAM Investors reported no remaining Wave Life Sciences position as of Q1 2026 after selling out during the quarter.
  • EAM Investors sold 248,815 Wave Life Sciences shares in Q1 2026, an estimated $4.23M.
  • EAM Investors first reported a position in Wave Life Sciences in Q1 2018 and held it in 4 quarters.
  • EAM Investors's Wave Life Sciences position peaked at $4.23M in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on EAM Investors's 13F filing for Q1 2026, filed 13 May 2026.